| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.90B | 41.15B | 37.86B | 35.51B | 34.37B | 33.50B |
| Gross Profit | 8.72B | 8.69B | 7.19B | 6.40B | 6.32B | 5.81B |
| EBITDA | 6.50B | 6.54B | 5.32B | 4.44B | 4.08B | 3.62B |
| Net Income | 3.78B | 3.92B | 2.93B | 2.70B | 2.28B | 537.54M |
Balance Sheet | ||||||
| Total Assets | 34.60B | 37.62B | 37.07B | 35.90B | 34.51B | 29.97B |
| Cash, Cash Equivalents and Short-Term Investments | 20.58B | 20.74B | 20.94B | 19.33B | 17.30B | 11.02B |
| Total Debt | 7.84B | 8.76B | 12.42B | 15.88B | 15.93B | 13.61B |
| Total Liabilities | 15.18B | 18.11B | 20.97B | 22.31B | 22.54B | 19.97B |
| Stockholders Equity | 19.42B | 19.51B | 16.11B | 13.58B | 11.98B | 10.01B |
Cash Flow | ||||||
| Free Cash Flow | 3.27B | 3.77B | 5.31B | 1.87B | 3.20B | 1.83B |
| Operating Cash Flow | 3.55B | 4.21B | 5.60B | 2.74B | 3.88B | 2.47B |
| Investing Cash Flow | -74.15M | -162.96M | -6.40M | 411.66M | 413.00M | 190.84M |
| Financing Cash Flow | -2.97B | -4.24B | -3.98B | -1.11B | 1.98B | 2.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥62.02B | 11.71 | ― | 1.68% | 9.24% | 4.31% | |
78 Outperform | ¥17.43B | 15.74 | ― | 1.49% | 1.23% | 0.12% | |
66 Neutral | ¥70.38B | 12.14 | ― | 2.18% | 12.03% | 30.12% | |
65 Neutral | ¥39.90B | 18.51 | ― | 2.59% | 4.02% | 18.12% | |
65 Neutral | ¥18.56B | 30.65 | ― | 1.13% | 3.37% | 9.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥6.27B | 19.21 | ― | 2.29% | 0.08% | 105.25% |